Title: PUBLIC ISSUE OF 3,433,500 EQUITY SHARES OF Rs.10 EACH AT A PRICE OF Rs. 175/- FOR CASH AGGREGATING Rs. 600.86 MILLION (REFERRED TO AS THE "ISSUE"). THE ISSUE WOULD CONSTITUTE 25.01% OF THE FULLY DILUTED POST ISSUE PAID-UP CAPITAL OF THE COMPANY.
Abstract: The Issue is being made through the 100% book building process where upto 50% of the Issue shall be issued on a discretionary basis to Qualified Institutional Buyers. Further, not less than 25% of the Issue shall be available for allocation on a proportionate basis to NonInstitutional bidders and not less than 25% of the Issue shall be available for allocation on a proportionate basis to retail bidders, subject to valid bids being received at or above the Issue Price. RISK IN RELATION TO FIRST ISSUE This being the first issue of Equity Shares of Dishman Pharmaceuticals and Chemicals Limited (the “Company”), there has been no formal market for the Equity Shares of the Company. The Issue Price (as determined by the Company, in consultation with the Book Running Lead Managers, on the basis of assessment of market demand for the Equity Shares by way of book building) should not be taken to be indicative of the market price of the Equity Shares after the Equity Shares are listed. No assurance can be given regarding an active and/ or sustained trading in the Equity Shares of the Company nor regarding the price at which the Equity Shares will be traded after listing. GENERAL RISKS Investments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in this Issue unless they can afford to take the risk of losing their investment. Investors are advised to read the risk factors carefully before taking an investment decision in this Offering. For taking an investment decision, investors must rely on their own examination of the Company and the Issue including the risks involved. The Equity Shares offered in the Issue have not been recommended or approved by the Securities and Exchange Board of India (“SEBI”), nor does SEBI guarantee the accuracy or adequacy of this Prospectus. Specific attention of the investors is invited to the summarized and detailed statements in Risk Factors beginning on page iv.
Publication Year: 2004
Publication Date: 2004-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot